CO5261532A1 - SILILATED HETEROCICLIC COMPOUNDS, PROCEDURE FOR THE PREPARATION OF THESE AND PHARMACEUTICAL COMPOSITION CONTAINING THEM - Google Patents

SILILATED HETEROCICLIC COMPOUNDS, PROCEDURE FOR THE PREPARATION OF THESE AND PHARMACEUTICAL COMPOSITION CONTAINING THEM

Info

Publication number
CO5261532A1
CO5261532A1 CO00084393A CO00084393A CO5261532A1 CO 5261532 A1 CO5261532 A1 CO 5261532A1 CO 00084393 A CO00084393 A CO 00084393A CO 00084393 A CO00084393 A CO 00084393A CO 5261532 A1 CO5261532 A1 CO 5261532A1
Authority
CO
Colombia
Prior art keywords
preparation
pharmaceutical composition
composition containing
carbon atoms
sililated
Prior art date
Application number
CO00084393A
Other languages
Spanish (es)
Inventor
Joachim Mozulak
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO5261532A1 publication Critical patent/CO5261532A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con un compuesto de la fórmula I:<EMI FILE="00084393_1" ID="1" IMF=JPEG >en donde X es CH2 u O, R1 es hidrógeno, alquilo (de 1 a 4 átomos de carbono), alquenilo (de 3 a 5 átomos de carbono) en donde el doble enlace no está adyacente al átomo de nitrógeno, o bencilo, R2 es hidroxilo o alcoxilo (de 1 a 4 átomos de carbono), y R3, R4, y R5, son independientemente alquilo (de 1 a 4 átomos de carbono), en forma de base libre o de sal de adición de ácido. Igualmente, se refiere al proceso para la preparación de dicho compuesto y a una composición farmacéutica que lo contiene.The present invention relates to a compound of the formula I: <EMI FILE = "00084393_1" ID = "1" MFI = JPEG> wherein X is CH2 or O, R1 is hydrogen, alkyl (from 1 to 4 carbon atoms ), alkenyl (3 to 5 carbon atoms) where the double bond is not adjacent to the nitrogen atom, or benzyl, R2 is hydroxyl or alkoxy (1 to 4 carbon atoms), and R3, R4, and R5 , are independently alkyl (from 1 to 4 carbon atoms), in the form of free base or acid addition salt. It also refers to the process for the preparation of said compound and a pharmaceutical composition containing it.

CO00084393A 1999-11-15 2000-11-07 SILILATED HETEROCICLIC COMPOUNDS, PROCEDURE FOR THE PREPARATION OF THESE AND PHARMACEUTICAL COMPOSITION CONTAINING THEM CO5261532A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19954847 1999-11-15

Publications (1)

Publication Number Publication Date
CO5261532A1 true CO5261532A1 (en) 2003-03-31

Family

ID=7929072

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00084393A CO5261532A1 (en) 1999-11-15 2000-11-07 SILILATED HETEROCICLIC COMPOUNDS, PROCEDURE FOR THE PREPARATION OF THESE AND PHARMACEUTICAL COMPOSITION CONTAINING THEM

Country Status (6)

Country Link
AR (1) AR026451A1 (en)
AU (1) AU2356301A (en)
CO (1) CO5261532A1 (en)
EC (1) ECSP003761A (en)
PE (1) PE20011023A1 (en)
WO (1) WO2001036428A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200092955A (en) 2017-11-24 2020-08-04 하. 룬드벡 아크티에셀스카브 New catecholamine prodrug for use in the treatment of Parkinson's disease
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689892A1 (en) * 1992-04-09 1993-10-15 Rhone Poulenc Rorer Sa New 4-substd. 1,4-di:phenyl-1-sila:cyclopentane derivs. - used as serotonin antagonists e.g. for treating anxiety, migraine, asthma or hypertension
US6210705B1 (en) * 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate

Also Published As

Publication number Publication date
ECSP003761A (en) 2002-06-26
AR026451A1 (en) 2003-02-12
AU2356301A (en) 2001-05-30
WO2001036428A1 (en) 2001-05-25
PE20011023A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
NZ511739A (en) New esters derived from substituted phenyl-cyclohexyl compounds
CO5140093A1 (en) MODIFIED EPOTILONES C 21
DOP2005000071A (en) &#34;METHYL-ARIL OR HETEROARIL-AMIDA SUBSTITUTED COMPOUNDS&#34;
IL154272A (en) Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
DOP2005000076A (en) &#34;ORTOSUSTITUTED ARIL-O HETEROARILAMIDE COMPOUNDS&#34;
ECSP066405A (en) ARIL OR HETEROARIL AMIDA COMPOUNDS
PE2799A1 (en) LACTAMS AND HETERO-CYCLIC IMIDES OF ARALQUILO AND ARALQUILIDENO
HUT46675A (en) Process for producing piperidine derivatives and pharmaceutical compositions comprising such compounds
AR005462A1 (en) A PROCESS TO PREPARE CERTAIN CYCLOHEXAPEPTIDES AND COMPOUNDS OBTAINED THROUGH SUCH A PROCEDURE.
ES2121441T3 (en) NEW DERIVATIVES OF 3,5-DIOXO - (2H, 4H) - 1,2,4 - TRIAZINE, ITS PREPARATION AND APPLICATION AS A PHARMACY
AR031597A1 (en) PIPERIDINE COMPOUNDS, A PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS, AND THE USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR USE AS CCR-3 INHIBITORS
CO5271675A1 (en) DECAHIDRO-ISOQUINOLINAS DERIVATIVES, PROCESS FOR THE PREPARATION, COMPOSITION AND PHARMACEUTICAL COMPOUNDS CONTAINING THEM
CO5170512A1 (en) TETRAHYDROQUINOLIN PIPERIDINE DERIVATIVES
CO4990932A1 (en) DERIVATIVES OF 2,1,3-BENZOTIADIAZOLE AND PROCESS FOR ITS PREPARATION
CO5140104A1 (en) MEVINOLINE DERIVATIVES AND PHARMACEUTICAL PREPARATION CONTAINING THEM
DE60229054D1 (en) SYNTHESIS OF CYCLOPENTADIVES DERIVATIVES
TW427979B (en) A condensed piperidine compound
NO990578L (en) Diesel fuel containing oxygenated compounds
CO5261532A1 (en) SILILATED HETEROCICLIC COMPOUNDS, PROCEDURE FOR THE PREPARATION OF THESE AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
MX9206127A (en) ACETYLENE COMPOUNDS
PT763024E (en) NEW PROCESSES AND INTERMEDIARIES FOR THE PREPARATION OF PIPERAZINE DERIVATIVES
CO5140099A1 (en) CERTAIN SUBSTITUTED CAPROLACTAMAS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND ITS USE IN TUMORS TREATMENT
CO5200762A1 (en) PREPARATION OF PIPERIDIN-4-SUBSTITUTED WAVES
EA200100059A2 (en) New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them
ES2060079T3 (en) PROCEDURE FOR THE PREPARATION OF A CARBOXIALKYL-ETER FROM 2-AMINO-7-HYDROXITETRALINE.

Legal Events

Date Code Title Description
FA Application withdrawn